Cinven, a private equity firm, completed the acquisition of a 72% stake in Synlab Services, a German human and veterinary laboratory services company, from BC Partners, an investment firm, for €1.7bn. "Cinven's deal origination relies strongly on our matrix of deep sector and regional expertise. Our investments first in Labco and now Synlab perfectly illustrate how our Healthcare and regional German and French teams have worked closely together to execute our expansion strategy within the European laboratory diagnostics market. We have been extremely impressed by both these businesses and are looking forward to working with both management teams to achieve significant growth in the future," Stuart McAlpine, Cinven Partner.